← Back to catalogue
Villacryl Opaker Kit 2x7gr powder (pink)+ 12ml liquid +12ml primer
EUDAMEDClass IIa (EU MDR)
Ref V210Z12Model VILLACRYL OPAKER
Identity
- Trade Name
- Villacryl Opaker Kit 2x7gr powder (pink)+ 12ml liquid +12ml primer EUDAMEDVILLACRYL OPAKER 2x7 gr powder (pink )+12 ml liquid+12 ml primer EUDAMED
- Device Name
- Villacryl Opaker Kit 2x7gr powder (pink)+ 12ml liquid +12ml primer EUDAMED
- Model / Reference
- V210Z12 EUDAMEDVILLACRYL OPAKER EUDAMED
Identifiers
- Primary DI / UDI-DI
- 05901602121993 EUDAMED
- Basic UDI-DI
- B-05901602121993 EUDAMED590160212CROEH EUDAMED
- EMDN Code
- Q010699 MATERIALS FOR THE PREPARATION OF CUSTOM-MADE DENTAL DEVICES - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Poland EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMEDEUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Villacryl Opaker Kit 2x7gr powder (pink)+ 12ml liquid +12ml primer by Everall7 Spółka Z Ograniczoną Odpowiedzialnością — Class IIa — MDR, MDD — listed in…
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | B-05901602121993 | Class IIa | Active |
| EUDAMED | European Union | CE/MDD | B-05901602121993 | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Everall7 Spółka Z Ograniczoną Odpowiedzialnością
- EUDAMED SRN
- PL-MF-000018646
Sources (2)
- EUDAMED b37ac85e-f227-4652-a988-708f3aa92899 61 fields · synced Oct 6, 2026
- EUDAMED dbf796dd-c26b-490c-8de6-b61e5b6728e7 61 fields · synced Jul 10, 2026